LEES PHARMACEUTICAL HLDGS revenue for the last year amounted to 1.05 B HKD, the most of which — 585.76 M HKD — came from its highest performing source at the moment, Proprietary and Generic Products, the year earlier bringing 499.81 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought LEES PHARMACEUTICAL HLDGS 1.05 B HKD, and the year before that — 1.23 B HKD.